Guerbet SA (LON:0ELV)
London · Delayed Price · Currency is GBP · Price in EUR 14.18
+0.42 (3.05%)
Feb 10, 2026, 10:49 AM GMT
Guerbet Market Cap
Guerbet has a market cap or net worth of 153.9 million as of February 12, 2026. Its market cap has decreased by -46.21% in one year.
Market Cap
153.90M
Enterprise Value
456.16M
Revenue
703.68M
Ranking
n/a
PE Ratio
23.20
Stock Price
14.18
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has increased from 101.49M to 153.90M, an increase of 51.65%. That is a compound annual growth rate of 1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 153.90M | -2.10% |
| Dec 31, 2025 | 157.20M | -43.75% |
| Dec 31, 2024 | 279.45M | 30.83% |
| Dec 29, 2023 | 213.59M | 12.46% |
| Dec 30, 2022 | 189.93M | -51.87% |
| Dec 31, 2021 | 394.61M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Tristel | 203.19M |
| Animalcare Group | 194.71M |
| Optima Health | 189.54M |
| Diaceutics | 142.24M |